Combined treatment of cisplatin and overexpression of caspase-activated deoxyribonuclease (CAD) promotes apoptosis in vitro and in vivo

Oral Oncology

Volumn 40, Issue 4, 2004, Pages 390-399

  Kimura, Yuichi ^a   Sugimoto, Chizuru ^a   Matsukawa, Shigeru ^a   Sunaga, Hiroshi ^a   Igawa, Hideki ^a   Yamamoto, Hideyuki ^a   Ito, Toshihisa ^a   Saito, Hitoshi ^a   Fujieda, Shigeharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Cisplatin; Gene gun; Gene therapy; Head and neck squamous cell carcinoma

Indexed keywords

CASPASE; CISPLATIN; DEOXYRIBONUCLEASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER THERAPY; DRUG EFFECT; ENZYME ACTIVATION; GENE GUN; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; L CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

EID: 1242338043     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.07.001     Document Type: Article

References (22)

1. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
2. Peitsch M.C., Polzar B., Stephan H.et al. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 12:1993;371-377.
3. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond.). 391:1998;43-50.
4. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhivitor in CAD activation and DNA degradation during apoptosis. Nature (Lond.). 391:1998;96-99.
5. Enari M., Hase A., Nagata S. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14:1995;5201-5208.
6. Dubrez L., Savoy I., Hamman A., Solary E. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathway. EMBO J. 15:1996;5504-5512.
7. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:1997;223-233.
8. Phelan A., Elliott G., O'hare P. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nature Bio. 16:1998;440-443.
9. Sugimoto C., Matsukawa S., Fujieda S.et al. Involvement of intercellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line. Anticancer Res. 16:1996;675-680.
10. Grabenbauer G.G., Suckorada O., Niedobitek G.et al. Cisplatin induces apoptosis in oral squamous carcinoma cells by the mitochondria-mediated but not the NF-kappaB-suppressed pathway. Oral Oncol. 39:2003;282-289.
11. Yang N.S., Sun W.H. Gene gun and other non-viral approaches for cancer gene therapy. Nature Med. 1:1995;481-483.
12. Sugimoto C., Fujieda S., Seki M.et al. Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo. Int. J. Cancer. 82:1999;860-867.
13. Melamed M.R., Kamentsky L.A., Boyse E.A. Cytotoxic test automation: a live-dead cell differential counter. Science. 163(864):1969;285-286.
14. Yamada T., Fujieda S., Yanagi S.et al. Protein-tyrosine kinase syk expressed in human nasal fibroblasts and its effect on RANTES production. J. Immunol. 166:2001;538-543.
15. Matsumoto N., Saito H., Miyoshi N., Nakanishi K., Fukuda M. Combination effect of hyperthermia and photodynamic therapy on carcinoma. Arch. Otolaryngol. Head Neck Surg. 116:1990;824-829.
16. Noda I., Fujieda S., Seki M.et al. Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells. Int. J. Cancer. 80:1999;279-284.
17. Tsuzuki H., Fujieda S., Sunaga H., Noda I., Saito H. Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma. Cancer Res. 58:1998;794-800.
18. Fujieda S., Inuzuka M., Tanaka N.et al. Expression of p27 is associated with bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int. J. Cancer. 84:1999;315-320.
19. Li D., Au J.L. Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein. Pharm. Res. 18:2001;907-913.
20. Mizutani Y., Nakao M., Ogawa O., Yoshida O., Bonavida B., Miki T. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. J. Urol. 165:2001;263-270.
21. Tsuchiya H., Mori Y., Ueda Y., Okada G., Tomita K. Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma. Anticancer Res. 20:2000;235-242.
22. Asselin E., Mills G.B., Tsang B.K. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res. 61:2001;1862-1868.